HCPLive Network

Light Smoking Increases Rheumatoid Arthritis Risk in Women

THURSDAY, April 25 (HealthDay News) -- Even light smoking increases the risk of rheumatoid arthritis (RA) among women, and smoking cessation reduces but does not eliminate this risk, according to a study published online April 22 in Arthritis Research & Therapy.

Daniela Di Giuseppe, from the Karolinska Institutet, in Stockholm, and colleagues examined the effect of smoking intensity, duration, and cessation on the risk of RA using data from the Swedish Mammography Cohort, including 34,101 women (219 cases of RA) aged 54 to 89 years who were followed from 2003 through 2010.

The researchers found that the risk of RA correlated significantly with smoking intensity (one to seven cigarettes per day versus never smoking: relative risk, 2.31) and smoking duration (one to 25 years versus never smoking: relative risk, 1.60). The risk was significantly elevated even 15 years after smoking cessation, compared with never smokers (relative risk, 1.99). The risk of RA seemed to decrease with the time since stopping smoking. The risk was lower for women who stopped 15 years before the start of follow-up versus those who stopped one year before the start of follow-up (relative risk, 0.70; 95 percent confidence interval, 0.24 to 2.02).

"Our study indicated that even light smoking is associated with increased risk of RA for women. In extension to this, we showed that the risk of RA was decreasing over time after smoking cessation, but compared to never smokers the risk was still statistically significantly higher," the authors write. "The clearly increased risk of RA development even among former smokers is another reason to persuade women not to start smoking."

Abstract
Full Text

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Researchers at Hong Kong University and the Wellcome Trust Sanger Institute have identified a link between the influenza A viruses’ genetic diversity and severity of the infection.
Carol Burke, MD, FACG, FASGE, talks about her phase-3 placebo-controlled trial of Celecoxib in pediatric subjects with familial adenomatous polyposis (FAP) at the 2014 ACG Annual Meeting in Philadelphia, PA.
Carol Burke, MD, FACG, FASGE, discusses pediatric familial adenomatous polyposis (FAP) and colorectal cancer at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.
The immune system is the new focus of much work on traumatic brain injury (TBI). In a challenge to the paradigm that the blood brain barrier prevents harmful leukocytes from entering the brain, a Texas team tried to neutralize the impact of these cells. Peripheral lymphocytes are activated after TBI. They may then act as potential antigen presenting cells and get into the brain, causing cells there to degenerate.
Black women undergoing in vitro fertilization are only about half as likely as white women to become pregnant, and the racial disparity persists even when donor eggs are used. These findings are being presented at the annual meeting of the American Society for Reproductive Medicine, held from Oct. 18 to 22 in Honolulu.
Hospital conversion to for-profit status is associated with improvements in financial margins, but has no effect on process quality metrics or mortality rates, according to a study published in the Oct. 22/29 issue of the Journal of the American Medical Association
Drinking sugar-sweetened sodas may affect cellular aging by shortening telomere length, according to research published online Oct. 16 in the American Journal of Public Health.
More Reading